CClinicalTrials.gg
Status unknownNCT03559478Updated Oct 9, 2018

Sharp Dissection Versus Monopolar Electrocautery in Primary Total Knee Arthroplasty Performed Under Tourniquet

An interventional study of Sharp dissection with scalpel plus electrocautery to vessels and Electrocautery for all dissection in Osteo Arthritis Knee and Arthroplasty, Replacement, Knee, sponsored by Royal Infirmary of Edinburgh. Status unknown at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2018-10-09.

Sponsored by Royal Infirmary of Edinburgh · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Sex
All
01

Study summary

This study compares the use of sharp dissection with diathermy for the approach to a total knee replacement. Half of the patients will be randomly assigned each intervention.

Read the detailed description

The approach to the knee to carry out a total knee replacement (TKR) can either be carried out using a scalpel, sharp dissection, or using an electric current to divide tissue, monopoly electrocautery. Reducing blood loss is important. Blood loss can result in anaemia, which has a number of effects including shortness of breath, chest pain and lethargy. Blood loss into a newly replaced knee can also result in pain and stiffness in the joint. Total knee replacements are routinely carried out with a tourniquet inflated, which reduces the blood flow into to leg during the operation. Diathermy is applied to areas of bleeding to stop them from doing so during operations. With the tourniquet inflated, some areas that would bleed when this was deflated may not be noticed and continue to bleed. Using diathermy for the approach would be expected to reduce this bleeding compared to using a scalpel.

02

Conditions studied

  • Osteo Arthritis Knee
  • Arthroplasty, Replacement, Knee
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's planned enrollment of 70 is close to the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Royal Infirmary of Edinburgh is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Primary knee osteoarthritis requiring TKA (total knee arthroplasty)
  • Planned for cruciate retaining prosthesis without patella resurfacing
  • Patient is able to give informed consent
  • Patient resides locally and will be available for follow up

Exclusion criteria

Exclusion Criteria:

  • Cardiac pacemaker
  • Inflammatory arthropathy
  • Tourniquet contraindicated
  • Thrombophilia/haemoglobinopathy
  • Spinal anaesthetic not possible
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
70 participants (estimated)

Study arms

  • Active comparator
    Treatment Group 1

    Sharp dissection with scalpel plus electrocautery to vessels

    Procedure: Sharp dissection with scalpel plus electrocautery to vessels

  • Active comparator
    Treatment Group 2

    Electrocautery for all dissection

    Procedure: Electrocautery for all dissection

Interventions

  • ProcedureSharp dissection with scalpel plus electrocautery to vessels

    A scalpel will be used for dissection for TKA implantation. Bleeding vessels will be managed as encountered with electrocautery. Electrocautery will not be used for dissection.

  • ProcedureElectrocautery for all dissection

    Skin incision will be made with a scalpel, but all other dissection will be performed with electrocautery.

06

What researchers measure

Primary outcomes

  1. 24hr Calculated blood loss

    Will be done using the Nadler and Gross formulae

    Time frame: 1 day

Secondary outcomes

  1. Haemoglobin drop

    Haemoglobin drop from day 1 full blood count test

    Time frame: 1 day

  2. Transfusion requirement

    If the patient requires blood transfusion or not

    Time frame: 2 days

  3. VAS (Visual Analogue Scale) pain score 24 and 48 hrs

    Patient's pain score at 24 and 48 hours post-operatively

    Time frame: 2 days

  4. Range of motion 48hrs and 6 weeks

    Knee range of motion in degrees at 48 hours and 6 weeks post-operatively

    Time frame: 6 weeks

  5. Length of hospital stay

    Length of inpatient stay in hospital

    Time frame: 2 weeks

  6. Improvement in Oxford knee score at 12 months

    Oxford Knee Score, designed to assess function and pain after total knee replacement. Scored from 0 (severe knee symptoms with functional limitation) to 60 (absence of pain and limitations)

    Time frame: 12 months

  7. Adverse events

    Any complications encountered

    Time frame: 12 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 9, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03559478
Lead sponsor
Royal Infirmary of Edinburgh
Responsible party
Chloe Scott (Consultant Trauma and Orthopaedic Surgeon, Royal Infirmary of Edinburgh) — Principal investigator
First posted
Jun 18, 2018
Start date
Nov 2018 (estimated)
Primary completion
Apr 2021 (estimated)
Completion
Apr 2021 (estimated)
Last update
Oct 9, 2018

Study contacts

Chloe EH Scott, MD MSc
Contact
chloe.scott@nhslothian.scot.nhs.uk
01312423484
Katrina R Bell, MBChB
Contact
katrinabell@doctors.org.uk
01312423480
Chloe EH Scott, MD MSc
principal investigator · Consultant Trauma and Orthopaedic Surgeon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion